Company & Sponsor Intelligence
Icahn School of Medicine at Mount Sinai
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials14
Recruiting2
Completed11
Countries1
Therapeutic footprint
adhdalzheimersanxietyautismdepressioneating_disordersepilepsymovement_disordersother_psychiatryschizophreniasubstance_usetraumatic_brain_injury
Indexed studies
NCT05769634Electrophysiologic Studies of Cognition in Epilepsy Patients
epilepsy · United StatesNA
epilepsy · United StatesNA
NCT01678209Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach
adhd · United StatesPHASE4
adhd · United StatesPHASE4
NCT07344233Neurofeedback During Naturalistic Stimuli to Reduce Craving in Heroin Addiction
substance_use · United StatesNA
substance_use · United StatesNA
NCT04213079Treatments of Mal de Debarquement Syndrome (MdDS) by Habituation of Velocity Storage
movement_disorders · United StatesNA
movement_disorders · United StatesNA
NCT00233129Improving Executive Functions After Traumatic Brain Injury (TBI): A Clinical Trial of the "Executive Plus" Program
traumatic_brain_injury · United StatesNA
traumatic_brain_injury · United StatesNA
NCT01816152Methodology Issues in a Tailored Light Treatment for Persons With Dementia
depression · United StatesNA
depression · United StatesNA
NCT07745374Safety and Feasibility of DBS for Bipolar Depression
depression · United StatesNA
depression · United StatesNA
NCT05239780Invasive Decoding and Stimulation of Altered Reward Computations in Depression Patients
depression · United StatesNA
depression · United StatesNA
NCT00211809CBT as an Adjunct to SRIs in the Treatment of BDD
other_psychiatry · United StatesPHASE4
other_psychiatry · United StatesPHASE4
NCT07102810Hypnosis-Based Machine Learning Biomarker Study
anxiety · United StatesNA
anxiety · United StatesNA
NCT07216768ADAPT: Approach to Dance for Autism
autism · United StatesNA
autism · United StatesNA
NCT00044655Switching Medication to Treat Schizophrenia
schizophrenia · PHASE4
schizophrenia · PHASE4
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →